RPG Life Sciences

2,358.30
-41.00
(-1.71%)
Market Cap
3,900.40 Cr
EPS
53.01
PE Ratio
33.62
Dividend Yield
1.00 %
Industry
Healthcare
52 Week High
2,974.95
52 Week Low
1,515.00
PB Ratio
7.50
Debt to Equity
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,650.20
#1 3,95,938.26
35.26
#1 49,887.20
12.06
#1 9,648
-18.99
37.34
6,538.00
1,73,563.36
81.05
8,184.00
0.89
1,600
23.05
52.08
1,503.50
1,21,424.91
23.39
26,520.70
14.17
4,155
30.28
52.05
3,255.40
1,10,177.53
57.55
10,785.70
11.59
1,656
10.91
56.33
1,318.80
1,10,047.97
19.87
28,905.40
12.36
5,578
21.14
63.44
2,353.20
97,087.98
49.19
10,615.60
19.57
1,942
-10.91
39.14
957.65
96,362.00
20.99
19,831.50
13.82
3,831
-0.19
60.07
1,944.00
88,751.56
27.98
20,141.50
#1 19.94
1,936
#1 112.49
41.19
31,800.00
67,572.78
47.56
6,097.20
10.80
1,201
27.83
63.26
1,109.70
64,451.56
#1 19.23
29,559.20
17.55
3,169
-0.50
35.82
Forecast
Actual
Growth Rate
Revenue Growth
13.85 %
Net Income Growth
29.73 %
Cash Flow Change
3.90 %
ROE
6.37 %
ROCE
6.57 %
EBITDA Margin (Avg.)
10.59 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
243
280
294
345
331
376
390
443
518
589
776
Expenses
228
256
266
306
297
316
319
354
410
454
521
EBITDA
15
24
28
39
34
60
71
89
108
135
255
Operating Profit %
6 %
8 %
9 %
11 %
10 %
16 %
18 %
20 %
20 %
22 %
20 %
Depreciation
11
10
11
14
15
16
17
16
16
17
22
Interest
3
3
3
4
4
2
1
1
0
0
1
Profit Before Tax
1
12
15
20
15
37
54
73
92
118
233
Tax
0
0
3
7
4
7
14
22
24
30
50
Net Profit
1
12
12
14
11
29
40
52
68
88
183
EPS in ₹
0.60
7.03
12.70
8.13
6.54
17.54
24.19
31.13
40.90
53.01
110.80

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
197
205
247
291
251
267
303
345
419
513
Fixed Assets
105
109
137
131
128
123
113
104
124
114
Current Assets
86
87
96
143
97
126
176
207
264
298
Capital Work in Progress
1
2
2
9
17
10
12
31
25
96
Investments
0
0
0
0
0
0
0
0
58
91
Other Assets
92
94
108
152
106
134
178
210
211
212
Total Liabilities
197
205
247
291
251
267
303
345
419
513
Current Liabilities
67
67
79
121
78
83
80
80
103
131
Non Current Liabilities
5
5
21
16
13
8
7
9
9
7
Total Equity
125
134
147
155
161
177
216
256
308
375
Reserve & Surplus
112
120
134
142
147
163
203
243
294
362
Share Capital
13
13
13
13
13
13
13
13
13
13

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
1
-1
0
0
40
17
-32
-5
Investing Activities
-10
-15
-30
-16
-19
-11
-8
-35
-106
-79
Operating Activities
-2
33
7
15
46
50
58
65
91
94
Financing Activities
12
-18
23
0
-27
-39
-11
-14
-17
-20

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
72.07 %
72.07 %
72.07 %
72.07 %
72.07 %
72.41 %
72.61 %
72.61 %
72.81 %
72.81 %
72.81 %
72.81 %
72.81 %
72.81 %
72.81 %
72.95 %
72.95 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.46 %
0.56 %
0.89 %
1.14 %
1.35 %
1.30 %
1.45 %
DIIs
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
2.04 %
2.02 %
2.12 %
2.29 %
3.59 %
3.79 %
4.19 %
4.63 %
5.45 %
6.06 %
6.14 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
20.45 %
20.59 %
20.58 %
20.65 %
20.85 %
20.37 %
19.91 %
20.26 %
19.91 %
19.45 %
18.41 %
18.16 %
17.41 %
16.79 %
15.92 %
15.58 %
15.33 %
Others
7.47 %
7.33 %
7.34 %
7.28 %
7.07 %
7.21 %
5.44 %
5.10 %
5.16 %
5.45 %
4.73 %
4.67 %
4.70 %
4.62 %
4.47 %
4.11 %
4.12 %
No of Share Holders
18,701
20,564
23,674
22,768
22,821
22,115
20,757
21,360
20,837
20,226
21,088
21,866
22,137
22,232
23,481
24,891
24,867

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 2.8 2.4 2.4 4 7.2 9.6 12 16 0.00
Dividend Yield (%) 0.00 0.73 0.97 1.41 1.03 1.28 1.4 0.79 0.7 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
16 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
16 Jul 2025 2,341.50 2,404.25
27 Jun 2025 DIVIDEND Dividend
₹ 4.00 /share
27 Jun 2025 2,244.30 2,404.25
27 Jun 2025 DIVIDEND Dividend
₹ 20.00 /share
27 Jun 2025 2,244.30 2,404.25
28 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Apr 2025 2,197.25 2,244.30
24 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Jan 2025 2,067.10 2,166.65
07 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2024 2,443.95 2,673.90
16 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
16 Jul 2024 1,535.60 1,640.55
28 Jun 2024 DIVIDEND Dividend
₹ 16.00 /share
28 Jun 2024 1,560.55 1,599.95
21 Jul 2023 DIVIDEND Dividend
₹ 12.00 /share
21 Jul 2023 820.55 996.65
15 Jul 2022 DIVIDEND Dividend
₹ 9.60 /share
14 Jul 2022 589.35 568.55
17 Aug 2021 DIVIDEND Dividend
₹ 7.20 /share
13 Aug 2021 490.80 516.85

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication1 day ago
Intimation Of Record Date For 18Th AGM Of The Company Scheduled On July 16 2025. 3 days ago
Email Communication To Shareholders Regarding Dividend Taxation ProvisionsJun 05, 2025
Further To Our Letter Dated April 28 2025 We Enclose Herewith Updated Annexure C Pursuant To Details Required As Per SEBI Circular No. SEBI/HO/CFD/CFD-Pod-1/P/CIR/2023/123 Dated July 132023.Jun 03, 2025
Intimation To Shareholders Holding Shares In Physical Mode Regarding Furnishing Of PAN KYC Details And NominationJun 03, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJun 02, 2025
In Accordance With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") To Shareholders Whose Shares Are Liable To Be Transferred To IEPF Authority.Jun 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 29, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 23, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 05, 2025
Earning Call Audio Recording Link For Q$ Ended On March 31 2025.Apr 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 29, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationApr 29, 2025
Amendment Of PoliciesApr 28, 2025
Disclosure Under 30(5) Of SEBI (Listing Obligations And Disclosure Requirement) Regulations 2015Apr 28, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 28, 2025
Corporate Action-Board approves DividendApr 28, 2025
Appointment Of Secretarial Auditor For Term Of Five (5) YearsApr 28, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateApr 28, 2025
Financial Result For Quarter And Year Ended On March 31 2025Apr 28, 2025
Board Meeting Outcome for Audited Financial Result For Quarter And Year Ended On March 31 2025Apr 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 23, 2025
Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI LODR 2015 This Is To Inform You That A Meeting Of The Board Of Directors Of The Company Is Scheduled On Monday April 28 2025Apr 21, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 19, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 11, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 08, 2025
Closure of Trading WindowMar 25, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Mar 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 25, 2025
Update On Transfer Of Surplus Vacant Leasehold LandFeb 13, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 25, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 24, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Jan 24, 2025
Integrated Filing (Financial)Jan 24, 2025
Unaudited Financial Results For The Period Ended December 31 2024Jan 24, 2025
Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held On January 24 2025Jan 24, 2025
Board Meeting Intimation for Approval Of The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024Jan 17, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Intimation Of Incidence Of Fire At The Manufacturing Plant Located At Navi Mumbai.Jan 03, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 27, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 16, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 13, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 09, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 06, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 03, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 29, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 25, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportNov 15, 2024

Technical Indicators

RSI(14)
Neutral
68.19
ATR(14)
Volatile
87.56
STOCH(9,6)
Neutral
70.08
STOCH RSI(14)
Overbought
91.68
MACD(12,26)
Bullish
23.91
ADX(14)
Weak Trend
24.44
UO(9)
Bearish
48.70
ROC(12)
Uptrend But Slowing Down
8.12
WillR(14)
Neutral
-29.85

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Mirae Asset Multicap Fund Direct - Growth
0.98%
-15845
-0.12%
-0.28%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
1.09%
4501
0.30%
0.24%
Motilal Oswal Quant Fund Direct-Growth
0.54%
-1808
-0.32%
-0.40%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.07%
0
0.00%
-0.01%
Quant Active Fund Direct-Growth
0.39%
0
0.00%
-0.04%
Quant Healthcare Fund Direct - Growth
7.87%
0
-0.08%
-1.41%
Union Small Cap Fund Direct-Growth
0.77%
0
-0.02%
-0.11%